Amber Watt accepts new patients on Medical News Today.
Amber Watt
Be the first to review this provider!
Kansas City, MO
Accepting new patients
Clinical Overview
Amber Watt works in Kansas City, MO as
Office Locations
-
Amber Watt4050 Broadway Blvd Ste 220, Kansas City, MO 64111
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Amber Watt?
Step 1 of 3
Your review of Amber Watt
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Pulmonary Diagnostics
Respiratory Therapy
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Amber Watt's office is located at 4050 Broadway Blvd Ste 220 Kansas City, MO 64111. Get a map and directions to Amber Watt's office here.
Amber Watt does not have any reviews yet.
Claim Your Profile
Are you Amber Watt?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
In a real-world study, an AI algorithm increased aneurysm detection on CT scans. Notably, the AI and radiologists had different strengths, suggesting that combining AI with physician interpretation could improve aneurysm detection.
A recent study has found that higher glycoprotein acetyls (GlycA) levels, a marker of inflammation, are linked with an increased risk of heart problems, including heart attack, heart failure, and stroke.
According to a recent review, cefepime was associated with increased mortality compared with other β-lactam antibiotics. Cefepime is used for the treatment of conditions such as pneumonia and bacterial meningitis.
